Welcome to our dedicated page for Warby Parker SEC filings (Ticker: WRBY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Warby Parker Inc.'s SEC filings document the formal disclosures of a Delaware public benefit corporation whose Class A common stock trades on the New York Stock Exchange under WRBY. Form 8-K reports furnish quarterly and annual operating results, including revenue, SG&A, adjusted EBITDA, customer metrics, cash flow, and store activity, and also record material events such as share repurchase authorization and executive-officer transitions.
Proxy materials describe annual meeting matters, director elections, auditor ratification, advisory executive-compensation votes, and voting rights for Class A and Class B common stock. Other filings cover capital-structure disclosures, Regulation FD product-development announcements, governance matters, and exhibits tied to the company's public-company reporting obligations.
Warby Parker Inc. reports that a director and Co‑Chief Executive Officer converted 150,000 shares of Class B common stock into Class A common stock at an exercise price of $0 on 01/06/2026, then sold 150,000 Class A shares the same day in three transactions. The sales were made under a Rule 10b5‑1 trading plan adopted on September 16, 2025, at reported prices including an average price of $24.29 for one tranche, with other sales at $24.99 and $25.99 per share.
Following these transactions, the reporting person directly holds 37,119 shares of Class A common stock and also reports indirect ownership of additional Class A shares through multiple trusts, alongside substantial remaining Class B holdings that are convertible into Class A on a one‑to‑one basis subject to specified conditions.
Warby Parker Inc.'s Co-Chief Executive Officer and director reported planned share transactions in Class A Common Stock. On 01/02/2026, the reporting person converted 25,000 shares of Class B Common Stock into Class A at a conversion price of $0 and sold 25,000 Class A shares at an average price of $22.46, leaving 37,247 Class A shares held directly.
On 01/06/2026, a further 50,000 Class B shares were converted into Class A at $0 and 50,000 Class A shares were sold at an average price of $24.29, with 37,247 Class A shares still held directly afterward. The filing notes that these sales were made under a Rule 10b5-1 trading plan adopted on September 16, 2025. Following these transactions, the reporting person also holds 4,784,923 derivative securities linked to Class B Common Stock directly and 1,656,770 related derivative securities indirectly through the David A. Gilboa 2012 Family Trust.
An insider of WRBY plans to sell 150,000 common shares, with an aggregate market value of $3,487,500, through Morgan Stanley Smith Barney LLC on or around January 6, 2026. These shares, acquired on June 28, 2017 via previously exercised options and restricted stock units for cash, are part of the issuer’s 105,727,103 common shares outstanding. Over the past three months, the same insider has already sold 100,000 common shares under a Rule 10b5-1 trading plan for gross proceeds of $3,028,820. By signing the notice, the insider represents not knowing any undisclosed material adverse information about the issuer’s current or prospective operations.
Insider David Gilboa filed a notice to sell 50,000 shares of common stock under Rule 144. The planned sale is through Morgan Stanley Smith Barney LLC on or around 01/06/2026 on the NYSE, with an aggregate market value of $1,162,500.00. The issuer had 105,727,103 shares of this class outstanding.
The 50,000 shares were acquired on 06/28/2017 from the issuer via previously exercised options and restricted stock units, paid in cash. In the past three months, Gilboa already sold 25,000 common shares on 01/02/2026 for $561,585.00 and 200,000 common shares on 12/11/2025 for $6,040,800.00 under 10b5-1 trading arrangements.
WRBY filed a notice that a shareholder plans to sell 25,000 common shares through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $544,750.00. The filing notes that 105,727,103 shares of this class were outstanding and the approximate sale date is 01/02/2026.
The 25,000 shares were acquired on 06/28/2017 via previously exercised options and restricted stock units, paid in cash. The document also reports prior Rule 10b5-1 activity: on 12/11/2025, 200,000 common shares were sold for gross proceeds of $6,040,800.00 for the account of David Gilboa. The signer represents they are not aware of undisclosed material adverse information about the issuer.
Warby Parker Inc. insider and Co-Chief Executive Officer David Gilboa reported a transfer and conversion of company stock. On 12/16/2025, 50,000 shares of Class B Common Stock were transferred as a bona fide gift to a donor-advised fund and, upon transfer, automatically converted into 50,000 shares of Class A Common Stock on a one-to-one basis.
After these transactions, the reporting person beneficially owned 4,859,923 shares of Class B Common Stock directly and 1,656,770 shares of Class A Common Stock indirectly through the David A. Gilboa 2012 Family Trust. Warby Parker’s dual-class structure allows Class B shares to convert into Class A shares at any time at the holder’s option and includes automatic conversion triggers tied to transfers, specified dates, and certain changes in the roles or status of key founders.
Warby Parker Inc. director Joel Cutler reported several indirect transactions in Class A common stock of Warby Parker Inc. (WRBY) on 12/16/2025. The Joel E Cutler Revocable Trust transferred 20,000 shares as a gift at a reported price of $0, and the Randi & Joel Cutler Family Foundation received 20,000 shares as a gift at $0. The foundation then sold 19,932 shares at a weighted average price of $26.0123 per share. After these transactions, the foundation is reported to hold 20,000 shares indirectly. The filing notes that the sale price reflects multiple trades between $25.79 and $26.25 per share.
A holder of WRBY Class A common stock has filed a notice of proposed sale under Rule 144 covering 32,249 shares, with an approximate sale date of 12/16/2025. The shares are expected to be sold through Goldman Sachs & Co. LLC on the NYSE, with an aggregate market value of $859,435.85.
The securities to be sold were originally acquired in two transactions: 19,932 shares were received as a gift on 12/16/2021 from the Joel Cutler Revocable Trust, and 12,317 shares were acquired from the issuer in a public offering on 09/29/2021. The issuer had 105,727,103 Class A common shares outstanding as reported in the notice; this is a baseline figure, not the amount being sold.
Warby Parker Inc. reported an insider stock sale by one of its directors. On December 11, 2025, the director sold 38,832 shares of Warby Parker Class A common stock at a price of $29.07 per share.
After this transaction, the director directly beneficially owned 27,057 shares of Warby Parker stock. The filing indicates that the report was made by a single reporting person in their capacity as a director of the company.
Warby Parker Inc. reported that a director and Co-Chief Executive Officer executed pre-planned stock transactions on December 11, 2025. The insider converted 100,000 shares of Class B Common Stock into Class A at an exercise price of $0, then sold 100,000 Class A shares at an average price of $30.29 in multiple trades between $30.00 and $30.90 under a Rule 10b5-1 trading plan adopted on March 14, 2025.
After these trades, the insider directly owns 37,119 Class A shares and indirectly owns 200,000 Class A shares each through the Royal Blue Aries Trust and the Tiffany Blue Gemini Trust. The insider also holds 3,299,271 Class B shares directly and additional Class B shares through several family trusts, all convertible into Class A on a one-to-one basis, with automatic conversion triggers including transfers outside permitted ownership groups, October 1, 2031, and specified changes in the roles, employment, death, or disability of Neil Blumenthal and Dave Gilboa.